LC/MS Analysis of Oseltamavir (Tamiflu) and Oseltamavir Carboxylate on SeQuant® ZIC-HILIC

LC/MS Analysis of Oseltamavir (Tamiflu) and Oseltamavir Carboxylate on SeQuant® ZIC-HILIC

Conditions

column SeQuant ZIC-HILIC, PEEK, 20 x 2.1 mm, 3.5 μm, 100 Å (1.50439.0001)
mobile phase [A] acetonitrile; [B] ammonium acetate; (85:15, A:B)
flow rate 1.0 mL/min
detector Agilent 1200 LC-system coupled online to an API5000 triple quadrupole
injection: 2.5 μL

Description

Featured Industry Life Science and Biopharma
Legal Information SeQuant is a registered trademark of Merck KGaA, Darmstadt, Germany
suitability application for LC-MS

Materials

     
Related Links